News Release

06/12/2012

Release

Patent Allowance for Pirfenidone／F647 and its Derivative’s Use in Radiation-Caused Lung Injury

06/04/2012

Release

Notice of Subsidiary Company Establishment of Shanghai Genomics Inc.

02/29/2012

Release

Notice for Manufacturing and Distribution Permission regarding IPF treatment drug, F647

02/14/2012

Release

Announcement of the 11th Annual General Shareholder Meeting

01/31/2012

Release

Notice for Exercise of the 35th Round of Stock Options in January, 2012 and Completion of its Exercise

01/30/2012

Release

F351 Patents and Development Update

01/12/2012

Release

Notice for Large Volume Exercise of the 35th Round of Stock Options

01/05/2012

Release

Notice for Large Volume Exercise of the 35th Round of Stock Options

01/04/2012

Release

Notice for Exercise of the 35th Round of Stock Options in December, 2011